Jennifer R. Brown, MD, PhD, on Treating CLL/SLL With Ibrutinib: Findings From the RESONATE Trial

Posted: Tuesday, September 10, 2019

Jennifer R. Brown, MD, PhD, of Dana-Farber Cancer Institute, discusses the long-term final findings on the use of ibrutinib and how she expects it will be positioned in the treatment landscape for chronic lymphocytic leukemia or small lymphocytic lymphoma.